Mesenchymal Stromal Cells for Graft-versus-Host Disease: A Trilogy.
作者信息
Galipeau Jacques
机构信息
From the Department of Medicine and Carbone Cancer Center, University of Wisconsin in Madison, Madison, Wisconsin.
出版信息
Biol Blood Marrow Transplant. 2020 May;26(5):e89-e91. doi: 10.1016/j.bbmt.2020.02.023. Epub 2020 Mar 7.
Abstract
摘要
相似文献
1
Mesenchymal Stromal Cells for Graft-versus-Host Disease: A Trilogy.
Biol Blood Marrow Transplant. 2020 May;26(5):e89-e91. doi: 10.1016/j.bbmt.2020.02.023. Epub 2020 Mar 7.
2
Commentary: Role of Mesenchymal Stromal Cell-Mediated Crosstalk with Macrophages in Graft-versus-Host Disease and Tissue Repair.
Biol Blood Marrow Transplant. 2017 Jun;23(6):861-862. doi: 10.1016/j.bbmt.2017.04.006. Epub 2017 Apr 7.
3
Early cessation of a randomised study in acute graft versus host disease: upfront mesenchymal stromal cells with corticosteroids versus corticosteroids alone.
Bone Marrow Transplant. 2020 Nov;55(11):2199-2201. doi: 10.1038/s41409-020-0955-9. Epub 2020 May 27.
4
Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: A case report.
J Cell Mol Med. 2022 Jan;26(2):588-592. doi: 10.1111/jcmm.17114. Epub 2021 Dec 6.
5
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
Front Immunol. 2020 Oct 19;11:567210. doi: 10.3389/fimmu.2020.567210. eCollection 2020.
6
Differences in Protein Secretion by Multipotent Mesenchymal Stromal Cells Effective and Ineffective in the Prevention of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Bull Exp Biol Med. 2022 May;173(1):128-132. doi: 10.1007/s10517-022-05507-1. Epub 2022 May 27.
7
Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.
Mol Ther. 2019 Aug 7;27(8):1436-1451. doi: 10.1016/j.ymthe.2019.05.007. Epub 2019 May 16.
8
Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease.
Stem Cells Dev. 2021 Mar;30(5):234-246. doi: 10.1089/scd.2020.0191. Epub 2021 Feb 19.
9
Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
Haematologica. 2016 Aug;101(8):985-94. doi: 10.3324/haematol.2015.140368. Epub 2016 May 12.
10
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease.
Haematologica. 2010 Dec;95(12):2102-10. doi: 10.3324/haematol.2010.028910. Epub 2010 Aug 26.
引用本文的文献
1
From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence.
Front Bioeng Biotechnol. 2025 Jul 30;13:1639439. doi: 10.3389/fbioe.2025.1639439. eCollection 2025.
2
Microbiological Aspects of Pharmaceutical Manufacturing of Adipose-Derived Stem Cell-Based Medicinal Products.
Cells. 2023 Feb 21;12(5):680. doi: 10.3390/cells12050680.
3
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
Front Immunol. 2022 Sep 14;13:959658. doi: 10.3389/fimmu.2022.959658. eCollection 2022.
4
The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review.
Biomater Transl. 2022 Mar 28;3(1):31-54. doi: 10.12336/biomatertransl.2022.01.005. eCollection 2022.
5
Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells.
J Adv Res. 2022 Jul;39:73-88. doi: 10.1016/j.jare.2021.11.003. Epub 2021 Nov 19.
6
Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics.
Curr Stem Cell Rep. 2022;8(2):72-92. doi: 10.1007/s40778-022-00212-1. Epub 2022 Apr 27.
7
Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.
Stem Cell Res Ther. 2022 Mar 4;13(1):93. doi: 10.1186/s13287-022-02751-0.
8
Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids.
Cytotherapy. 2022 Jun;24(6):608-618. doi: 10.1016/j.jcyt.2021.12.009. Epub 2022 Feb 19.
9
The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing.
Cells. 2021 Nov 2;10(11):2982. doi: 10.3390/cells10112982.
10
IFN-γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease.
Stem Cells Transl Med. 2021 Nov;10(11):1561-1574. doi: 10.1002/sctm.21-0008. Epub 2021 Aug 16.
本文引用的文献
1
Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children.
Biol Blood Marrow Transplant. 2020 May;26(5):855-864. doi: 10.1016/j.bbmt.2020.01.026. Epub 2020 Feb 7.
2
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2020 May;26(5):845-854. doi: 10.1016/j.bbmt.2020.01.018. Epub 2020 Feb 1.
3
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2020 May;26(5):835-844. doi: 10.1016/j.bbmt.2019.08.029. Epub 2019 Sep 7.
4
Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Front Immunol. 2018 Dec 4;9:2837. doi: 10.3389/fimmu.2018.02837. eCollection 2018.
5
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.
Cell Stem Cell. 2018 Jun 1;22(6):824-833. doi: 10.1016/j.stem.2018.05.004.
6
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
Lancet. 2016 Sep 24;388(10051):1281-90. doi: 10.1016/S0140-6736(16)31203-X. Epub 2016 Jul 29.
7
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.
Nat Immunol. 2014 Nov;15(11):1009-16. doi: 10.1038/ni.3002.
8
Mesenchymal stromal cells: sensors and switchers of inflammation.
Cell Stem Cell. 2013 Oct 3;13(4):392-402. doi: 10.1016/j.stem.2013.09.006.
9
MSCs: science and trials.
Nat Med. 2013 Jul;19(7):812-3. doi: 10.1038/nm.3222.
10
MSCs: science and trials.
Nat Med. 2013 Jul;19(7):812. doi: 10.1038/nm.3220.
Zotero 插件